Dr. Vikas Chopra, MD

Dr. Chopra practices at UCLA Medical Center in Los Angeles, California.

Dr. Chopra's NPI, 1518027424, was assigned on December 11, 2006. Dr. Chopra graduated from Penn State College of Medicine in 1996. Dr. Chopra holds California license A87805.

Dr. Chopra's primary practice is UCLA Medical Center, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 206-4083.

Dr. Chopra's primary practice is UCLA Medical Center in Los Angeles, California. Dmand AI also links Dr. Chopra to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chopra practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Chopra's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Chopra is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Chopra's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma, glaucoma surgery and inflammation of iris among the conditions Dr. Chopra treats.

CMS data shows 5,053 Medicare services from Dr. Chopra across 20 procedure codes in 2024, for 1,013 Medicare patients. Medicare paid $445,451 for them.

CMS counts 1,013 Medicare patients who saw Dr. Chopra in 2024. The largest group is 75 to 84, with 444 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chopra's median patient age at 72, with 59% women.

In 2024, Dr. Chopra wrote 6,307 Medicare Part D claims for 858 patients. 57% of them were for generic drugs. CMS names the drug for 6,228 of them, across 34 drugs with 11 or more claims each, at $733,832 in total drug cost. In 2023, CMS named 6,243 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Chopra for performance year 2024, reported as part of a group. Dr. Chopra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 46 procedures of cataract surgery by Dr. Chopra, more than 62% of the clinicians it reports for that procedure.

Dmand AI links 76 papers to Dr. Chopra, published from 2011 to 2025. 2016 was the busiest year, with 19. The most frequent topics are Tomography, Optical Coherence, Intraocular Pressure and Glaucoma. Dr. Chopra has published most often in J Glaucoma. Dr. Chopra's most frequent co-authors are Brian A. Francis, MD, Srinivas Reddy Sadda, MD and Alex Ansun Huang, MD.

Dmand AI links Dr. Chopra to 1 clinical trial. Conditions studied include Glaucoma, Open-Angle and Glaucoma.

CMS Open Payments shows 44 general payments to Dr. Chopra from 11 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 50% of the total. Alcon Laboratories Inc paid the most, $4,972.

Dmand AI lists 3 awards for Dr. Chopra, most recently Achievement Award in 2013.

Dr. Chopra graduated from Penn State College of Medicine in 1996. Dr. Chopra is a member of AAO and American Glaucoma Society.

Dr. Chopra is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.